The Efficacy of Different Follow-Up Strategies in Clinical Stage I Non-Seminomatous Germ Cell Cancer: A Markov Simulation Study
- 31 August 2005
- journal article
- Published by Elsevier in European Urology
- Vol. 48 (2) , 258-268
- https://doi.org/10.1016/j.eururo.2005.04.021
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Comparison of surveillance and retroperitoneal lymph node dissection in Stage I nonseminomatous germ cell tumorsUrology, 2002
- SURVEILLANCE CAN BE THE STANDARD OF CARE FOR STAGE I NONSEMINOMATOUS TESTICULAR TUMORS AND EVEN HIGH RISK PATIENTSJournal of Urology, 2001
- EAU Guidelines on Testicular CancerEuropean Urology, 2001
- Surgery versus surveillance in stage I non-seminoma testicular cancerSeminars in Surgical Oncology, 1999
- A RATIONAL APPROACH TO MANAGING STAGE I NONSEMINOMATOUS GERM CELL CANCERUrologic Clinics of North America, 1998
- COST-EFFECTIVE STRATEGIES FOR THE FOLLOW-UP OF PATIENTS WITH GERM CELL TUMORSUrologic Clinics of North America, 1998
- Markov Models in Medical Decision MakingMedical Decision Making, 1993
- Primary Retroperitoneal Lymph Node Dissection in Clinical Stage A Non‐seminomatous Germ Cell Testis Cancer Review of the Indiana University Experience 1965–1989British Journal of Urology, 1993
- The Markov Process in Medical PrognosisMedical Decision Making, 1983
- ORCHIDECTOMY ALONE IN TESTICULAR STAGE I NON-SEMINOMATOUS GERM-CELL TUMOURSThe Lancet, 1982